GENVR vs TECH · rev $3.94B vs P/E 65, rev $1.22B
Gen Digital Inc. Contingent Value Rights (GENVR) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Gen Digital Inc. Contingent Value Rights (GENVR) common stock listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported GENVR revenue for 2025-03-28 was $3.94B. Net income was $643.0M. Revenue was up 3.6% from 2024-03-29 to 2025-03-28. GENVR currently screens at market cap $0.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
GENVR currently screens at market cap $0. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the GENVR and TECH stock pages for the full models.
Not investment advice.